Trust Indenture Act Section Contingent Value Rights Agreement Reference SectionContingent Value Rights Agreement • December 6th, 2005 • Atkins Nutritionals Holdings, Inc. • New York
CLASS B CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • August 4th, 2020 • Eros International PLC • Services-motion picture & video tape distribution • Delaware
This CLASS B CONTINGENT VALUE RIGHTS AGREEMENT, dated as of July 30, 2020 (this “Agreement”), is entered into by and among Eros International Plc, an Isle of Man company limited by shares (“Parent”), STX Filmworks, Inc., a Delaware corporation (the “Company”), Fortis Advisors LLC, a Delaware limited liability company, solely in its capacity as representative of the former holders of the Shares (in such capacity, the “Stockholders’ Representative”), and Computershare Inc., a Delaware corporation, and its wholly-owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company, collectively as rights agent (the “Rights Agent”) and as initial CVR Registrar (as defined herein).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • August 2nd, 2021 • New York
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of November 20, 2019 (this “CVR Agreement”), by and between Bristol-Myers Squibb Company, a Delaware corporation (the “C ompany”), and Equiniti Trust Company, a limited trust company organized under the laws of the state of New York, as trustee (the “Trustee”), in favor of each person who from time to time holds one or more Contingent Value Rights (the “Securities” or “ CVRs”) to receive cash payments in the amounts and subject to the terms and conditions set forth herein.
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • October 25th, 2011 • North American Financial Holdings, Inc. • National commercial banks • Tennessee
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of September 7, 2011 (this “Agreement”), is entered into by GREEN BANKSHARES, INC., a corporation organized under the laws of the State of Tennessee (the “Company”) for the benefit of the Holders (as defined herein).
FORM OF CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • January 30th, 2024 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated as of [_____], 2024, is entered into by and among AVROBIO, Inc., a Delaware corporation (the “Company”) and [_____], a [_____] corporation (“Rights Agent”).
CONTINGENT VALUE RIGHTS AGREEMENT by and between COMMUNITY HEALTH SYSTEMS, INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC Dated as of January 27, 2014Contingent Value Rights Agreement • January 28th, 2014 • Community Health Systems Inc • Services-general medical & surgical hospitals, nec • New York
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of January 27, 2014 (this “CVR Agreement”), by and between Community Health Systems, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company, as trustee (the “Trustee”), in favor of each person who from time to time holds one or more Contingent Value Rights (the “Securities” or “CVRs” and, each individually, a “Security” or a “CVR”) to receive cash payments in the amounts and subject to the terms and conditions set forth herein.
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • February 11th, 2004 • Arthrocare Corp • Electromedical & electrotherapeutic apparatus • Nevada
This CONTINGENT VALUE RIGHTS AGREEMENT, dated as of January 28, 2004 (this “Agreement”), is entered into by and among MEDICAL DEVICE ALLIANCE INC., a Nevada corporation (the “Company”), ARTHROCARE CORPORATION, a Delaware corporation (“Parent”), ALPHA MERGER SUB CORPORATION, a Nevada corporation (“Merger Sub”), Wells Fargo Bank, N.A. (the “Rights Agent”) and Frank Bumstead (the “Stockholders’ Agent”).
CONTINGENT VALUE RIGHTS AGREEMENT dated as of October 31, 2003 by and among INFORMATION RESOURCES, INC., GINGKO CORPORATION, GINGKO ACQUISITION CORP., THE RIGHTS AGENTS NAMED HEREIN AND INFORMATION RESOURCES, INC. LITIGATION CONTINGENT PAYMENT RIGHTS...Contingent Value Rights Agreement • November 12th, 2003 • Information Resources Litig Contingent Pymt Rights Trust • Services-engineering, accounting, research, management • Delaware
This CONTINGENT VALUE RIGHTS AGREEMENT, dated as of October 31, 2003 (this “Agreement”), is entered into by and among Information Resources, Inc. a Delaware corporation (the “Company”), Gingko Corporation, a Delaware corporation, (“Parent”) and Gingko Acquisition Corp., a Delaware corporation (“Merger Sub”), Joseph P. Durrett, Eileen Kamerick, William Chisholm and Bryan Taylor (individually and the Independent Rights Agent (as defined below), a “Rights Agent” and collectively and together with the Independent Rights Agent, the “Rights Agents”), and Information Resources, Inc. Litigation Contingent Payment Rights Trust, a Delaware statutory trust (the “CVR Trust”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • July 3rd, 2014 • Forest Laboratories, LLC • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of July 2, 2014 (this “Agreement”), is entered into by and between Forest Laboratories, LLC, a Delaware limited liability company (“Parent”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company, as Rights Agent.
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • October 28th, 2014 • Daiichi Sankyo Company, LTD • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of September [ ], 2014 (this “Agreement”), is entered into by and between Daiichi Sankyo Company, Limited, a Japanese corporation with its principal office at 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, Japan (“Parent”), and Broadridge Corporate Issuer Solutions, Inc., a Pennsylvania corporation, as Rights Agent (together with Parent, the “Parties”).
CASA LEY CONTINGENT VALUE RIGHTS AGREEMENT BY AND AMONG AB ACQUISITION LLC, SAFEWAY INC. THE SHAREHOLDER REPRESENTATIVE, AS DEFINED HEREIN AND COMPUTERSHARE INC. AND COMPUTERSHARE TRUST COMPANY, N.A., AS RIGHTS AGENT DATED AS OF JANUARY 30, 2015Contingent Value Rights Agreement • May 19th, 2017 • Safeway Stores 42, Inc. • Retail-grocery stores • Delaware
THIS CASA LEY CONTINGENT VALUE RIGHTS AGREEMENT, dated as of January 30, 2015 (this “Agreement”), is entered into by and among AB Acquisition LLC, a Delaware limited liability company (“Ultimate Parent”), Safeway Inc., a Delaware corporation (the “Company”), Computershare Inc. (“Computershare”) and its wholly owned subsidiary, Computershare Trust Company, N.A. together as rights agent (the “Rights Agent”) and the Shareholder Representative.
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • September 17th, 2013 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of September 11, 2013 (this “Agreement”), is entered into by and between Cubist Pharmaceuticals, Inc., a Delaware corporation (“Parent”), and Broadridge Corporate Issuer Solutions, Inc., a Pennsylvania corporation, as Rights Agent.
VIROLOGIC, INC. TO U.S. BANK NATIONAL ASSOCIATION as Trustee CONTINGENT VALUE RIGHTS AGREEMENT Dated as of December 10, 2004Contingent Value Rights Agreement • December 10th, 2004 • Virologic Inc • In vitro & in vivo diagnostic substances • Delaware
CONTINGENT VALUE RIGHTS AGREEMENT, dated as of December 10, 2004, between ViroLogic, Inc., a Delaware corporation (hereinafter called the “Company”), and U.S. Bank National Association, as trustee (hereinafter called the “Trustee”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • April 27th, 2021 • Palisade Bio, Inc. • Biological products, (no disgnostic substances) • Delaware
This Contingent Value Rights Agreement, dated as of April 27, 2021 (this “Agreement”), by and among Seneca Biopharma, Inc., a Delaware corporation (“Parent”), American Stock Transfer & Trust Company, LLC, as CVR Agent (the “CVR Agent”), and Raul Silvestre, in his capacity (as an individual and not in a legal capacity intended to create an attorney client relationship), as the initial CVR Holders’ Representative (the “CVR Holders’ Representative”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • June 10th, 2019 • GTX Inc /De/ • Pharmaceutical preparations • Delaware
This CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated as of June 7, 2019 (the “Effective Date”), is entered into by and between GTx, Inc., a Delaware corporation (“Parent”), Marc S. Hanover, as representative of the Holders (the “Holders’ Representative”), and Computershare Inc., as Rights Agent.
Form of CVR Agreement CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • August 10th, 2021 • Cellect Biotechnology Ltd. • Surgical & medical instruments & apparatus • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [___], 2021 (the “Agreement”), is entered into by and among Cellect Biotechnology, Ltd., an Israeli company (the “Company”), Mr. Eyal Leibovitz (the “Representative”), and Computershare Trust Company, N.A., a federally chartered trust company (the “Rights Agent”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • December 24th, 2009 • Neurogen Corp • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of December 23, 2009 (this “Agreement”, is entered into by and among Ligand Pharmaceuticals Incorporated, a Delaware corporation (“Buyer”), Neurogen Corporation, a Delaware corporation (“Target”), and Registrar and Transfer Company, a New Jersey corporation, as Rights Agent (the “Rights Agent”) and as initial Merck CVR Registrar (as defined herein).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • December 24th, 2009 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of December 23, 2009 (this “Agreement”, is entered into by and among Ligand Pharmaceuticals Incorporated, a Delaware corporation (“Buyer”), Neurogen Corporation, a Delaware corporation (“Target”), and Registrar and Transfer Company, a New Jersey corporation, as Rights Agent (the “Rights Agent”) and as initial Aplindore CVR Registrar (as defined herein).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • September 12th, 2003 • Alamosa Delaware Inc • Radio & tv broadcasting & communications equipment • New York
ContractContingent Value Rights Agreement • February 26th, 2021 • Third Point Reinsurance Ltd. • Fire, marine & casualty insurance
Form of] CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • March 8th, 2011 • Forest Laboratories Inc • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [—], 2011 (this “Agreement”), is entered into by and between FL HOLDING CV, an entity organized under the laws of the Netherlands (“Parent”), FOREST LABORATORIES, INC., a Delaware corporation (the “Guarantor”) and [ ], as Rights Agent (the “Rights Agent”).
FORM OF CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • May 23rd, 2023 • CohBar, Inc. • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated as of [●], 2023, is entered into by and among CohBar, Inc., a Delaware corporation (“Public Company”), and [●], as initial Rights Agent (as defined herein).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • November 20th, 2020 • F-Star Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of November 20, 2020 (this “Agreement”), is entered into by and among Spring Bank Pharmaceuticals, Inc., a Delaware corporation (the “Company”), F-Star Therapeutics Limited., a company registered in England and Wales with company number 11532458 (“F-Star”), Computershare Inc., a Delaware corporation (“Computershare”), and its wholly-owned subsidiary Computershare Trust Company, N.A., a federally chartered trust company (collectively with Computershare, the “Rights Agent”), and Martin Driscoll, acting solely in his capacity as representative of the Holders (as defined herein) (the “Holder Representative”). Capitalized terms not defined herein shall have the meanings ascribed to them in the Share Exchange Agreement (as defined below).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • November 6th, 2020 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated September 30, 2020, is by and between Ligand Pharmaceuticals Incorporated, a Delaware corporation (“Parent”) and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company, as rights agent (the “Rights Agent”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • March 29th, 2022 • Pineapple Holdings, Inc. • Telephone & telegraph apparatus • Minnesota
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of March 25, 2022 (this “Agreement”), by and among COMMUNICATIONS SYSTEMS, INC., a Minnesota corporation (the “Parent”), Equiniti Trust Company, as Rights Agent (the “Rights Agent”), and Richard A. Primuth, in his capacity as the initial CVR Holders’ Representative (the “CVR Holders’ Representative”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • August 14th, 2023 • Catalyst Biosciences, Inc. • Pharmaceutical preparations • New York
THIS CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated as of December 26, 2022 (the “Effective Date”), is entered into by and between Catalyst Biosciences, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability company, as initial Rights Agent (as defined herein).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • May 23rd, 2023 • Indivior PLC • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of March 2, 2023, (this “Agreement”), is entered into by and between Indivior Inc., a Delaware corporation (“Parent”), and Computershare Inc. (“Computershare”) and its affiliate, Computershare Trust Company, N.A., together, as Rights Agent (in such capacity, the “Rights Agent”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • December 24th, 2009 • Neurogen Corp • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of December 23, 2009 (this “Agreement”, is entered into by and among Ligand Pharmaceuticals Incorporated, a Delaware corporation (“Buyer”), Neurogen Corporation, a Delaware corporation (“Target”), and Registrar and Transfer Company, a New Jersey corporation, as Rights Agent (the “Rights Agent”) and as initial H3 CVR Registrar (as defined herein).
CONTINGENT VALUE RIGHTS AGREEMENT, dated as of August 21, 2018, by and among A. SCHULMAN, INC., as the Company, solely with respect to Sections 8.03, 8.05 through 8.12, and 8.14, LYONDELLBASELL INDUSTRIES N.V., as Parent, Joseph M. Gingo, John K....Contingent Value Rights Agreement • August 21st, 2018 • LyondellBasell Industries N.V. • Industrial organic chemicals
AGREEMENT (this “Agreement”), dated as of August 21, 2018, by and among A. Schulman, Inc., a Delaware corporation (the “Company”), Joseph M. Gingo, John K. Broussard, Jr. and David Leathers, as the initial Committee Members, and Equiniti Trust Company, as Paying Agent, and solely with respect to Sections 8.03, 8.05 through 8.12, and 8.14, LyondellBasell Industries N.V., a naamloze vennootschap (a public limited liability company) formed under the laws of The Netherlands (“Parent”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • December 24th, 2008 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of December 23, 2008 (this “Agreement”), is entered into by and among LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation (“Buyer”), PHARMACOPEIA, INC., a Delaware corporation (“Target”), and MELLON INVESTOR SERVICES LLC, a New Jersey limited liability company, as Rights Agent (the “Rights Agent”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • July 30th, 2021 • Ikonics Corp • Photographic equipment & supplies • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [●], 2021 (this “Agreement”), by and among IKONICS Corporation, a Minnesota corporation (“Parent”), Telluride Holdco, Inc., a Delaware corporation (“Holdco”), [●], as Rights Agent (the “Rights Agent”), and [●], in [its/his/her] capacity as the initial CVR Holders’ Representative (the “CVR Holders’ Representative”).
CONTINGENT VALUE RIGHTS AGREEMENT by and between Cubist Pharmaceuticals, Inc. and American Stock Transfer & Trust Company, LLC Dated as of October 24, 2013Contingent Value Rights Agreement • October 24th, 2013 • Cubist Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of October 24, 2013 (this “Agreement”), by and between Cubist Pharmaceuticals, Inc., a Delaware corporation (“Parent”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company, as trustee (the “Trustee”), in favor of each person who from time to time holds one or more Contingent Value Rights (the “Securities” or “CVRs”) to receive cash payments in the amounts and subject to the terms and conditions set forth herein.
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • June 7th, 2023 • Chijet Motor Company, Inc. • Motor vehicles & passenger car bodies • New York
This CONTINGENT VALUE RIGHTS AGREEMENT (as hereafter amended, restated, modified or supplemented in accordance herewith, this “Agreement”), dated as of June 1, 2023, is entered into by and between (i) Chijet Motor Company, Inc., a Cayman Islands exempted company (together with its successors, “Pubco”), and (ii) American Stock Transfer & Trust Company, LLC, as rights agent (the “Rights Agent”). Terms capitalized but not defined herein shall have the meaning ascribed to them in the BCA.
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • November 6th, 2020 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of November 5, 2020 (this “Agreement”), is entered into by and among Rexahn Pharmaceuticals, Inc., a Delaware corporation (“Parent”), Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as representative of the Holders (the “CVR Representative”), and Olde Monmouth Stock Transfer Co., Inc., as Rights Agent.
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • July 29th, 2020 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances) • Delaware
WHEREAS, Parent, TTP Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and Tetraphase Pharmaceuticals, Inc., a Delaware corporation (including in its capacity as the surviving corporation in the Merger, the “Company”), have entered into an Agreement and Plan of Merger dated as of June 24, 2020 (as it may be amended or supplemented from time to time pursuant to the terms thereof, the “Merger Agreement”);
